NICO Corporation

It has been one month since we welcomed NICO Corporation to Stryker! On September 20, it was announced that we completed the acquisition of NICO Corporation, a privately held company providing a systematic approach to minimally invasive surgery for tumor and intracerebral hemorrhage (ICH) procedures. This acquisition further strengthens our commitment to neurotechnology through tumor and stroke care. Together we are advancing neurosurgery and transforming lives! Learn more: https://lnkd.in/gpDA9Kw9 Follow us at Stryker Neurosurgical for more information and updates.

Did you know the Myriad can be used as a stand-alone small bore variable suction ranging from 3-10Fr? This functionality can be combined with the reciprocating blade to emulate the effect of precise microscissors. The foot pedal allows the user to toggle between these two functions without removing the Myriad from the field: therefore, minimizing reentry. Aspirated tissue is collected and preserved which is advantageous for tumor tissue analysis.

Attending CNS in Houston? Find NICO at booth 1721 and the Innovation Symposium. Learn more about the Myriad SPECTRA and the ENRICH trial results!

Recent publication concludes MIPS can be recommended within 24 hours of last known well (LKW) for lobar ICH 30-80 mL with EOTV goal <15 mL in patients 18-80 years without significant premorbid disability, following ENRICH. Read more here: https://bit.ly/4e3rrTa

Hand-held blue excitation light to complement your fluorescence guided surgical workflow - See how Dr. Tarek El Ahmadieh performs efficient GBM removal with Myriad SPECTRA.

Big news! The #ENRICHtrial results are out in NEJM Group showcasing groundbreaking success in minimally invasive removal of ICH! Think you've got what it takes to join a team that's transforming neurosurgical care? NICO Corporation is hiring! Let's make history together. Check out the career opportunities now available at NICO: https://bit.ly/4aAIRFC #werehiring #MedDeviceCareers

Did you know that the major skull-base surgery teaching programs use the Myriad? The Myriad is taught at multiple endonasal courses around the US including UPMC, OSU, Emory, CCF, Mayo Clinic, and Cornell. https://bit.ly/4cEw5pk

“Patients presenting with intracerebral hemorrhage deserve to be treated with the same urgency as patients arriving with acute ischemic stroke.” We agree! #CODEICH Read the full publication here: https://bit.ly/4cxhlsl

Watch Dr. Kimberly Hoang perform an efficient GBM resection with the Myriad SPECTRA to automate resection and enable hand-held blue excitation light. #neurosurgery #InnovativeMedicalDevices

Improvements in the treatment of intracerebral hemorrhage (ICH), the deadliest and most debilitating type of stroke, have finally been realized. We’re excited to share the positive results of the #ENRICHtrial showing minimally invasive surgery with BrainPath® and Myriad® is superior to the standard of care alone in ICH for appropriate patients. Here’s how: https://bit.ly/3TERbMN #innovation #neurosurgery #MIPS